Rocket Pharmaceuticals, Inc., incorporated on July 7, 1999 under Delaware law, is a fully integrated, late-stage biotechnology company dedicated to developing pioneering, first-in-class and best-in-class gene therapies. These therapies offer a targeted mechanism of action with clearly defined clinical endpoints, aimed at treating rare and debilitating diseases. The company is headquartered at 9 Cedarbrook Drive, Cranbury, NJ 08512. For more information, visit http://www.rocketpharma.com.

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for RCKT via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.